These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36150403)
1. Nesfatin-1 as a potential marker for functional hypothalamic amenorrhea. Szeliga A; Podfigurna A; Meczekalski B Gynecol Endocrinol; 2022 Nov; 38(11):992-996. PubMed ID: 36150403 [TBL] [Abstract][Full Text] [Related]
2. The influence of estro-progestin therapy on neurohormonal activity in functional hypothalamic amenorrhea. Szeliga A; Podfigurna A; Bala G; Meczekalski B Gynecol Endocrinol; 2022 Nov; 38(11):997-1002. PubMed ID: 36170883 [No Abstract] [Full Text] [Related]
3. Decreased plasma concentrations of brain-derived neurotrophic factor (BDNF) in patients with functional hypothalamic amenorrhea. Podfigurna-Stopa A; Casarosa E; Luisi M; Czyzyk A; Meczekalski B; Genazzani AR Gynecol Endocrinol; 2013 Sep; 29(9):817-20. PubMed ID: 23844985 [TBL] [Abstract][Full Text] [Related]
4. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. Laughlin GA; Dominguez CE; Yen SS J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412 [TBL] [Abstract][Full Text] [Related]
5. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function. Carmina E; Fruzzetti F; Lobo RA Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797 [TBL] [Abstract][Full Text] [Related]
7. Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Podfigurna-Stopa A; Pludowski P; Jaworski M; Lorenc R; Genazzani AR; Meczekalski B Gynecol Endocrinol; 2012 Apr; 28(4):299-304. PubMed ID: 21957879 [TBL] [Abstract][Full Text] [Related]
8. [Patients with functional hypothalamic amenorrhea are characterized by low serum inhibin B concentrations]. Podfigurna-Stopa A; Luisi S; Lazzeri L; Ciani V; Meczekalski B; Petraglia F Pol Merkur Lekarski; 2010 May; 28(167):350-3. PubMed ID: 20568395 [TBL] [Abstract][Full Text] [Related]
9. Cortisol levels alter the response to metoclopramide in patients with hypothalamic amenorrhea. Mendes MC; Ferriani RA; Costa LO; Moura MD; Silva de Sá MF Gynecol Endocrinol; 1995 Mar; 9(1):9-14. PubMed ID: 7793305 [TBL] [Abstract][Full Text] [Related]
10. Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis. Beitl K; Dewailly D; Seemann R; Hager M; Bünker J; Mayrhofer D; Holzer I; Ott J Front Endocrinol (Lausanne); 2022; 13():904706. PubMed ID: 35721741 [TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea. Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766 [TBL] [Abstract][Full Text] [Related]
12. Functional hypothalamic amenorrhea and its influence on women's health. Meczekalski B; Katulski K; Czyzyk A; Podfigurna-Stopa A; Maciejewska-Jeske M J Endocrinol Invest; 2014 Nov; 37(11):1049-56. PubMed ID: 25201001 [TBL] [Abstract][Full Text] [Related]
13. Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea. Brundu B; Loucks TL; Adler LJ; Cameron JL; Berga SL J Clin Endocrinol Metab; 2006 Apr; 91(4):1561-5. PubMed ID: 16464944 [TBL] [Abstract][Full Text] [Related]